Phase I dose escalation study of MM-121, a fully human monoclonal antibody to ErbB3, in patients with advanced solid tumors

被引:5
作者
Denlinger, Crystal S. [1 ]
Keedy, Vicki L. [2 ]
Cleary, James M. [3 ]
Kubasek, William [4 ]
Onsum, Matthew [4 ]
Moulis, Sharon [4 ]
Garcia, Gabriela [4 ]
Schoeberl, Birgit [4 ]
MacBeath, Gavin [4 ]
Nering, Rachel [4 ]
Murray, James [4 ]
Moyo, Victor [4 ]
Wong, Kwok-Kin [3 ]
Shapiro, Geoffrey [3 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Merrimack Pharmaceut, Cambridge, MA USA
关键词
D O I
10.1158/1538-7445.AM2011-LB-410
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-410
引用
收藏
页数:1
相关论文
empty
未找到相关数据